Prominent Indian Physician Verifies Huge Impact of Ivermectin in Curbing Second Delta-Variant Wave in India
TRIAL SITE IS A $5 SUBSCRIPTION….WELL WORTH IT
ARTICLE PASTED IN A COMMENT HERE
India’s largest State refused to stop Ivermection Use even after Pressure from the Indian Government and the WHO !
Heros
TrialSite chronicled closely the use of ivermectin-based home medicine kits in India’s largest state, Uttar Pradesh, and other states during the second wave of the pandemic starting in March and running through April. TrialSite shared that by June cases plummeted to what is today’s far more contained situation. TrialSite had accumulated evidence that the World Health Organization (WHO) wanted this covered up. So impressive was the Indian effort in Uttar Pradesh that WHO had to report on the success, less the material information that state and local health authorities use of ivermectin in their aggressive home-based test and treatment regimen. This effort is either omitted in Western mainstream media or discounted as not proven by what are often disqualified fact checkers. Recently a prominent Indian physician, Dr. Lenny Da Costa, went on the record to discuss “The True Story of India” involving ivermectin treatments there. While propaganda and misinformation in the West rages, the top Geriatrician, Preventive Cardiologist, and anti-aging specialist from the coastal Indian state of Goa gave a breakdown of exactly how ivermectin was used and what in fact were the results. He notes that the drug is still pervasively used despite media accounts to the contrary.
Uttar Pradesh’s Amazing Turnaround Against Delta Wave
As TrialSite shared with much of the world by May 12, Uttar Pradesh’s Director General of Medical and Health Services, Dr. Anshul Pareek led that state’s Health Department through the COVID-19 crises, establishing India’s most populated state with over 220 million people to become the first in the world’s second most populous nation to establish ivermectin as part of a large-scale prophylactic program with a focus on 1) close contacts of COVID-19 patients; 2) health workers and 3) general care of COVID-19 patients and eventually an aggressive home care program. WHO celebrated the Uttar Pradesh effort but censored material information–that ivermectin was an key part of the strategy to overcome the COVID-19 surge.
On May 28th TrialSite chronicled growing media suppression of the facts on the ground in India.
By May 30, 2021 TrialSite shared in “Unprecedented Pandemic Turnaround in Uttar Pradesh with Dramatic Decline in Cases: Time to Smell the Coffee” the incredible turnaround public health officials in Uttar Pradesh, a state with over 220 million people, accomplished using an ivermectin-based home treatment protocol. Days later on June 6 the rapid turnaround continued as reported in “Uttar Pradesh COVID-19 Case Decline Continues as Authorities Lift Restrictions in 72 of 75 State Districts: What was in those Medicine Kits?” While the WHO recognized the incredible work ongoing in India they omitted the use of ivermectin in what TrialSite considers some form of a coverup. Why would such material information be suppressed?
The Interview
Recently Dr. Lenny Da Costa verified all of the accounts TrialSite reported on this Spring. Dr. Da Costa shared that the home medicine kit included ivermectin, Doxycycline, Zinc, and Vitamin CI and in fact reports a new kit is now offered to kids there given the higher infection rates among that cohort.
Touting the incredible turnaround thanks to the aforementioned move by public health authorities in Uttar Pradesh, Da Costa shared with the interviewer verified the skyrocketing cases and the rapid decline, based on the massive public health program involving the free home medicine kits. Dr. La Costa declared that key to the success was the ability of ivermectin to inhibit transmission of the virus, especially among household contacts, which seemed to work incredibly well.
As Da Costa is from Goa, she shared on the account TrialSite reported on, that Goa backed off from the protocol due to reasons “other than healthcare” by June 20.
Media Propaganda and Misinformation
As TrialSite monitors clinical research and innovative care programs around the world during the pandemic Dr. La Costa verified what this media reported on—Western media censorship and material omission as to what was in fact working in India during the second Delta-triggered crisis.
La Costs reported that WHO’s Dr. Soumya Swaminathan issued warnings about the use of ivermectin that triggered a series of actions and reactions in India. For example a group of physicians and then lawyers filed lawsuits against the WHO director and WHO for criminal negligence, among other things. This created significant pressure within government as the WHO wields considerable clout not to mention a budget used for low-and-middle income countries.
Thus India’s apex research institute the India Council of Medical Research (ICMR) took down a recommendation for ivermectin. But that didn’t stop some states, including Uttar Pradesh from continuing to include the generic antiparasitic drug in its public health protocol targeting SARS-CoV-2. That’s because while the central government in India wields power it does not run medical care at the state level. Thus by June 29 with central authorities under pressure from the WHO to take down the ivermectin recommendation, states such as Uttar Pradesh doubled-down, even introducing a pediatric protocol, given the increased number of younger infections.
Da Costa reports also that a majority of physician practices use ivermectin at the local level, including himself, across the states in this vast country. He shared that “the successful containment in the second wave was primarily due to ivermectin, Doxycycline, Zinc and Vitamin C” treated early on, that is right when the first symptoms appear. Early care was the key to success in India turning around the deadly second, Delta variant-triggered surge.
The Profile: Dr. Lenny Da Costa
Dr. Lenny Da Costa is a Consultant Geriatrician, Preventive Cardiologist and anti-aging specialist. On qualifying from The Goa Medical College, he started his basic practice in Goa. It was during this period, he realized, that one of the biggest problems ailing the community was morbidity and mortality due to ageing.
This led him to do his specialty in Geriatric Medicine form M S Ramaiha Medical College Bangalore. On completion he pursued his training in the practice of Anti-aging and Preventive Cardiology.
He is amongst the few in the country certified by the International Board of Clinical Metal Toxicology USA as a FCMT, and the only one from Goa and Western Maharashtra (outside Mumbai) trained to administer chelation therapy.
He has also been certified by the Academy of Anti-Aging Medicine of India and Affiliate of the American Academy of Anti-Aging Medicine in the field Anti-Aging Medicine and in the use of Bio-identical Hormone Replacement Therapy. He has further trained in the use of Ozone Therapy under the auspices of Indian Ozone Society.
Dr. Da Costa is a member of a number of Medical Organizations including the IMA, IMA CGP, Research Society for the Study of Diabetes in India, GPA Greater Mumbai, Geriatric Society of India, to name a few. He is currently the Gen Secretary of the Indian Society for the Study of Metal Toxicology and Chelation Therapy (a nationwide organization that conducts workshops, training sessions, conferences for Chelation Therapy practitioners).
Dr. Da Costa has over the last 5 years treated more than 12000 patients suffering from IHD, CAD and other chronic degenerative disorders, all over Maharashtra and Goa. Dr Da Costa currently visits affiliate clinics in Ratnagiri, Chiplun, Mahad, Mangaon, Panvel, Mumbai, Thana, Nasik, Satana, Ahmednagar, Kholapur, Sangli while having his own clinic at Pune also.
Call to Action: Listen to the interview, read the numerous TrialSite accounts as well as hundreds of articles and interviews in India about the ivermectin-based home medicine kit that supported an amazing turnaround and is still in use today in Uttar Pradesh and some other states. Ask yourself why the media in the West censored this information? Why would the WHO commend the Uttar Pradesh effort publicly while omitting the involvement of ivermectin? Could it be that a confluence of governments, industry and NGOs already established a vaccine-centric pathway that couldn’t afford to have non-pharma competition, even with numerous real world data points that lives were being saved?